Potential biomarkers may predict response to TKIs in metastatic kidney cancer
A recent study published in Clinical Cancer Research and conducted in [...]
A recent study published in Clinical Cancer Research and conducted in [...]
Cabozantinib significantly improves overall survival in previously treated patients with [...]
Dr Naomi Haas from Abramson Cancer Centre, Philadelphia, presented an [...]
In his keynote lecture at the American Society for Clinical [...]
Results from a phase 1 clinical trial looking at CB-839, [...]
Data from the phase 3 METEOR trial published in the Journal [...]
Cabozantinib (Cabometyx) was more effective than everolimus (Afinitor) in people [...]
There are now a number of licensed drug options available [...]
The following article is a good review of the data [...]
Fantastic news for people with advanced kidney cancer: the lenvatinib [...]